{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifjqjzb6tp4k7xfduey6ddw7elnogxnjuduyadhse3iochfjnxcue",
    "uri": "at://did:plc:nnaxwirbqywidimahadp42bj/app.bsky.feed.post/3mlnuom7m2ph2"
  },
  "path": "/silence-therapeutics-to-participate-in-h-c-wainwright-bioconnect-investor-conference/",
  "publishedAt": "2026-05-12T12:09:29.000Z",
  "site": "https://www.cityam.com",
  "tags": [
    "Conference",
    "Webcast",
    "[...]"
  ],
  "textContent": "Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 19, 2026 at 2:00 p.m. ET. The live webcast can be [...]",
  "title": "Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference"
}